Web-Books
in the Austria-Forum
Austria-Forum
Web-Books
Naturwissenschaften
Chemie
Cancer Nanotheranostics - What Have We Learnd So Far?
Page - 93 -
  • User
  • Version
    • full version
    • text only version
  • Language
    • Deutsch - German
    • English

Page - 93 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Image of the Page - 93 -

Image of the Page - 93 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Text of the Page - 93 -

Conniotet al. Nanocarriers for immunecell targetingand tracking Torchilin, V. P. (2001). Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 73, 137–172. doi: 10.1016/S0168- 3659(01)00299-1 Torchilin, V. (2011). Tumor delivery ofmacromolecular drugs based on the EPR effect.Adv.DrugDeliv.Rev.63,131–135.doi:10.1016/j.addr.2010.03.011 Torchilin,V.P.(2008).Cellpenetratingpeptide-modifiedpharmaceuticalnanocar- riers for intracellular drug and gene delivery. Biopolymers 90, 604–610. doi: 10.1002/bip.20989 Toulza, F., Nosaka, K., Tanaka, Y., Schioppa, T., Balkwill, F., Taylor, G. P., et al. (2010).HumanT-lymphotropicvirus type1-inducedCCchemokine ligand22 maintainsahighfrequencyoffunctionalFoxP3+regulatoryTcells.J. Immunol. 185,183–189.doi:10.4049/jimmunol.0903846 Tsushima,H.,Kawata,S.,Tamura,S., Ito,N.,Shirai,Y.,Kiso,S., et al. (1996).High levels of transforming growth factor beta 1 in patientswith colorectal cancer: associationwithdiseaseprogression.Gastroenterology110,375–382. Unger,W.W.,andVanKooyk,Y.(2011).“Dressedforsuccess”C-type lectinrecep- tors for the delivery of glyco-vaccines to dendritic cells.Curr.Opin. Immunol. 23,131–137.doi:10.1016/j.coi.2010.11.011 U’ren,L.,Kedl,R.,andDow,S.(2006).Vaccinationwithliposome–DNAcomplexes elicits enhanced antitumor immunity.CancerGene. Ther. 13, 1033–1044. doi: 10.1038/sj.cgt.7700982 Uyttenhove, C., Godfraind, C., Lethe, B., Amar-Costesec, A., Renauld, J. C., Gajewski,T.F.,etal.(1997).TheexpressionofmousegeneP1Aintestisdoesnot preventsafe inductionofcytolyticTcellsagainstaP1A-encodedtumorantigen. Int. J.Cancer70,349–356. Vacchelli, E., Martins, I., Eggermont, A., Fridman, W. H., Galon, J., Sautes- Fridman, C., et al. (2012). Trial watch: peptide vaccines in cancer therapy. Oncoimmunology1,1557–1576.doi:10.4161/onci.22428 Van Broekhoven, C. L., Parish, C. R., Demangel, C., Britton, W. J., and Altin, J. G. (2004). Targeting dendritic cells with antigen-containing liposomes: a highlyeffectiveprocedure for inductionofantitumor immunityand for tumor immunotherapy.CancerRes.64, 4357–4365. doi: 10.1158/0008-5472.CAN-04- 0138 Van Kooyk, Y. (2008). C-type lectins on dendritic cells: keymodulators for the induction of immune responses. Biochem. Soc. Trans. 36, 1478–1481. doi: 10.1042/BST0361478 Vesely,M.D.,Kershaw,M.H., Schreiber, R.D., and Smyth,M. J. (2011).Natural innateandadaptive immunitytocancer.Annu.Rev. Immunol.29,235–271.doi: 10.1146/annurev-immunol-031210-101324 Vonderheide,R.H.,Bajor,D.L.,Winograd,R.,Evans,R.A.,Bayne,L.J.,andBeatty, G. L. (2013). CD40 immunotherapy for pancreatic cancer. Cancer Immunol. Immunother.62,949–954.doi:10.1007/s00262-013-1427-5 Voura, E. B., Jaiswal, J. K., Mattoussi, H., and Simon, S. M. (2004). Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat. Med. 10, 993–998. doi: 10.1038/nm1096 Vu-Quang, H., Muthiah, M., Lee, H. J., Kim, Y. K., Rhee, J. H., Lee, J. H., et al. (2012). Immune cell-specific delivery of beta-glucan-coated iron oxide nanoparticles fordiagnosinglivermetastasisbyMRimaging.Carbohydr.Polym. 87,1159–1168.doi:10.1016/j.carbpol.2011.08.091 Wang, H. X., Xiong, M. H., Wang, Y. C., Zhu, J., and Wang, J. (2013a). N-acetylgalactosamine functionalized mixed micellar nanoparticles for tar- geted delivery of siRNA to liver. J. Control. Release 166, 106–114. doi: 10.1016/j.jconrel.2012.12.017 Wang,K.,He, X., Yang, X., and Shi,H. (2013b). Functionalized silica nanoparti- cles:aplatformforfluorescence imagingat thecell andsmallanimal levels.Acc. Chem.Res.46,1367–1376.doi:10.1021/ar3001525 Wang,X.,Xing,X.,Zhang,B., Liu, F.,Cheng,Y., andShi,D. (2014). Surface engi- neeredantifoulingoptomagneticSPIONsforbimodal targeted imagingofpan- creaticcancercells. Int. J.Nanomedicine9,1601–1615.doi:10.2147/IJN.S58334 Wang, Y. X., Hussain, S.M., and Krestin, G. P. (2001). Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications inMR imaging.Eur.Radiol.11,2319–2331.doi:10.1007/s003300100908 Watkins, S.K.,Zhu,Z.,Riboldi,E., Shafer-Weaver,K.A., Stagliano,K.E., Sklavos, M.M.,etal. (2011).FOXO3programstumor-associatedDCstobecometolero- genic inhumanandmurineprostatecancer. J.Clin. Invest.121,1361–1372.doi: 10.1172/JCI44325 Weng,K.C.,Noble,C.O.,Papahadjopoulos-Sternberg,B.,Chen,F.F.,Drummond, D. C., Kirpotin, D. B., et al. (2008). Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes invitroand invivo.NanoLett.8,2851–2857.doi:10.1021/nl801488u Wesch, D., Peters, C., Oberg, H. H., Pietschmann, K., and Kabelitz, D. (2011). Modulationof gammadeltaTcell responsesbyTLR ligands.Cell.Mol. Life Sci. 68,2357–2370.doi:10.1007/s00018-011-0699-1 Wilson, J. T., Keller, S., Manganiello, M. J., Cheng, C., Lee, C. C., Opara, C., et al. (2013). pH-Responsive nanoparticle vaccines for dual-delivery of anti- gens and immunostimulatory oligonucleotides.ACSNano 7, 3912–3925. doi: 10.1021/nn305466z Wong, A. D., Dewit, M. A., and Gillies, E. R. (2012). Amplified release through the stimulus triggereddegradationof self-immolativeoligomers, den- drimers, and linear polymers. Adv. Drug Deliv. Rev. 64, 1031–1045. doi: 10.1016/j.addr.2011.09.012 Wu, D., Gao, Y., Qi, Y., Chen, L., Ma, Y., and Li, Y. (2014). Peptide-based can- cer therapy:opportunityandchallenge.CancerLett.351,13–22.doi: 10.1016/j. canlet.2014.05.002 Xiang, S.D., Scholzen,A.,Minigo,G.,David,C.,Apostolopoulos,V.,Mottram,P. L., etal. (2006).Pathogenrecognitionanddevelopmentofparticulatevaccines: does sizematter?Methods40,1–9.doi:10.1016/j.ymeth.2006.05.016 Xie, H., Diagaradjane, P., Deorukhkar, A. A., Goins, B., Bao, A., Phillips,W. T., et al. (2011). Integrin alphavbeta3-targeted gold nanoshells augment tumor vasculature-specific imagingand therapy. Int. J.Nanomedicine6,259–269.doi: 10.2147/IJN.S15479 Xie, J.,Chen,K.,Huang, J., Lee, S.,Wang, J.,Gao, J., et al. (2010).PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 31, 3016–3022. doi: 10.1016/j.biomaterials.2010.01.010 Xu, Z.,Wang, Y., Zhang, L., andHuang, L. (2014).Nanoparticle-delivered trans- forming growth factor-beta siRNA enhances vaccination against advanced melanoma bymodifying tumormicroenvironment.ACSNano 8, 3636–3645. doi:10.1021/nn500216y Yaghoubi, S. S., Jensen,M.C., Satyamurthy,N.,Budhiraja, S.,Paik,D.,Czernin, J., et al. (2009). Noninvasive detection of therapeutic cytolytic T cells with 18F- FHBG PET in a patient with glioma.Nat. Clin. Pract. Oncol. 6, 53–58. doi: 10.1038/ncponc1278 Yang, J., Lee, C. H., Ko, H. J., Suh, J. S., Yoon, H. G., Lee, K., et al. (2007). Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects onbreast cancer.Angew.Chem. Int. Ed.Engl.46, 8836–8839.doi:10.1002/anie.200703554 Yang,W., Cheng, Y., Xu, T., Wang, X., andWen, L. P. (2009). Targeting cancer cells with biotin-dendrimer conjugates. Eur. J.Med. Chem. 44, 862–868. doi: 10.1016/j.ejmech.2008.04.021 Yoo, H. S., and Park, T. G. (2004). Folate receptor targeted biodegrad- able polymeric doxorubicin micelles. J. Control. Release 96, 273–283. doi: 10.1016/j.jconrel.2004.02.003 Yoshikawa, T., Okada, N., Oda, A., Matsuo, K., Matsuo, K., Kayamuro, H., et al. (2008).Nanoparticles built by self-assemblyof amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effectorT cells.Vaccine26, 1303–1313. doi: 10.1016/j.vaccine.2007.12.037 Yu, M. K., Park, J., and Jon, S. (2012). Targeting strategies for multifunc- tional nanoparticles in cancer imaging and therapy.Theranostics 2, 3–44. doi: 10.7150/thno.3463 Yu,X.,Chen,L., Li,K., Li,Y.,Xiao, S., Luo,X., et al. (2007). Immunofluorescence detectionwithquantumdotbioconjugatesforhepatoma invivo.J.Biomed.Opt. 12,014008.doi:10.1117/1.2437744 Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., etal. (1995).Vascularpermeability inahumantumorxenograft:molecularsize dependenceandcutoff size.CancerRes.55,3752–3756. Yue,Z.G.,Wei,W., Lv, P. P., Yue,H.,Wang, L.Y., Su,Z.G., et al. (2011). Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles.Biomacromolecules12,2440–2446.doi:10.1021/bm101482r Zavaleta, C., De La Zerda, A., Liu, Z., Keren, S., Cheng, Z., Schipper, M., et al. (2008). Noninvasive Raman spectroscopy in livingmice for evaluation of tumor targeting with carbon nanotubes. Nano Lett. 8, 2800–2805. doi: 10.1021/nl801362a Zhang, L., Zhou, H., Belzile, O., Thorpe, P., and Zhao, D. (2014). Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice. J. Control. Release 183, 114–123. doi: 10.1016/j.jconrel.2014.03.043 Frontiers inChemistry | ChemicalEngineering November2014 |Volume2 |Article105 | 93
back to the  book Cancer Nanotheranostics - What Have We Learnd So Far?"
Cancer Nanotheranostics What Have We Learnd So Far?
Title
Cancer Nanotheranostics
Subtitle
What Have We Learnd So Far?
Authors
JoĂŁo Conde
Pedro Viana Baptista
JesĂşs M. De La Fuente
Furong Tian
Editor
Frontiers in Chemistry
Date
2016
Language
English
License
CC BY 4.0
ISBN
978-2-88919-776-7
Size
21.0 x 27.7 cm
Pages
132
Keywords
Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
Categories
Naturwissenschaften Chemie
Web-Books
Library
Privacy
Imprint
Austria-Forum
Austria-Forum
Web-Books
Cancer Nanotheranostics